Pilot trial suggests anti-inflammatory drug could help difficult-to-treat depression

AI Summary

A pilot randomized controlled trial led by the University of Bristol suggests that immunotherapy with an anti-inflammatory drug may be effective for treating difficult-to-treat depression. The findings were published in JAMA Psychiatry.

Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomized controlled clinical trial, published in JAMA Psychiatry.